Schistosomiasis mansoni
Conditions
Interventions
This study is not a clinical trial This is an observational cross sectional diagnostic accuracy study with a 30-day follow up for post treatment reassessment thus there is no randomization process T
and a drop in blood pressure, dizziness, and/or fainting due to vasovagal syncope In less significant numbers, there is the risk of accidental arterial puncture and, even more frequently, infection To
Sponsors
Instituto René Rachou
Instituto René Rachou
Eligibility
Age
7 Years to No maximum
Inclusion criteria
Inclusion criteria: living in an endemic area for schistosomiasis; over 7 years of age; both sexes; with or without S mansoni eggs in their feces determined by reading 18 slides of a stool sample using the Kato-Katz method
Exclusion criteria
Exclusion criteria: Participants screened as negative to Schistosoma mansoni infection who test positive for the presence of S mansoni eggs in a new stool sample collected after enrollment; Participants screened as having an active infection who report having received treatment with praziquantel between screening and study enrollment; Lactating; pregnant participants; individuals with impaired cognitive function; those unable to understand the study; Those who fail to provide one of the required biological samples
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At the end of the study, it is expected to determine the accuracy of the diagnostic tests evaluated | — |
Secondary
| Measure | Time frame |
|---|---|
| At the end of the study, it is expected to find agreement between the different tests, batches and operators for the commercial tests evaluated;At the end of the study, it is expected to find the percentage of co-infection among false-positive individuals and the percentage of positivity after therapeutic cure | — |
Countries
Brazil
Contacts
Public ContactCristina Fonseca
Instituto René Rachou
Outcome results
None listed